Q4 2023 Holdings
Filed 2024-02-14 | 202 holdings | $6.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $146.0M | 5,091,000 | 2.2% |
| Abbott Labs(ABT) | COM | 002824100 | $169.0M | 1,535,656 | 2.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $169.5M | 885,318 | 2.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $183.3M | 3,170,603 | 2.8% |
| Moderna Inc(MRNA) | COM | 60770K107 | $189.8M | 1,908,420 | 2.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $219.6M | 3,066,400 | 3.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $280.7M | 832,041 | 4.3% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $299.6M | 736,390 | 4.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $320.2M | 2,430,500 | 4.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $330.7M | 869,208 | 5.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $440.8M | 8,713,987 | 6.7% |